Boston, MA, United States of America

Teeru Bihani

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Teeru Bihani: Innovator in Breast Cancer Treatment

Introduction

Teeru Bihani is a notable inventor based in Boston, MA, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods for addressing AR+ breast cancer, he has secured two patents that highlight his expertise and dedication to improving patient outcomes.

Latest Patents

Bihani's latest patents include advanced methods for treating AR+ breast cancer. One of his patents describes a method that involves administering an AR agonist, such as SARMs like RAD140, in combination with various therapeutic agents. These agents include cdk4/6 inhibitors, m-TOR inhibitors, PI3k inhibitors, PARP inhibitors, BCL-2 inhibitors, and MCL-1 inhibitors. This innovative approach aims to enhance the effectiveness of cancer treatment and provide new hope for patients.

Career Highlights

Teeru Bihani has established himself as a key figure in the pharmaceutical industry, particularly through his work with Ellipses Pharma Limited. His commitment to research and development has led to groundbreaking advancements in cancer therapies, making him a respected inventor in his field.

Collaborations

Bihani collaborates with talented professionals in the industry, including Gary Hattersley and Jamal Saeh. These partnerships foster a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Teeru Bihani's contributions to breast cancer treatment through his patents and collaborations underscore his role as a leading inventor in the medical field. His work continues to inspire advancements in cancer therapies, ultimately benefiting patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…